These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 20197382)
1. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis. Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382 [TBL] [Abstract][Full Text] [Related]
2. Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis. Keller UB; Old JB; Dorsey FC; Nilsson JA; Nilsson L; MacLean KH; Chung L; Yang C; Spruck C; Boyd K; Reed SI; Cleveland JL EMBO J; 2007 May; 26(10):2562-74. PubMed ID: 17464290 [TBL] [Abstract][Full Text] [Related]
3. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells. Bhatt KV; Hu R; Spofford LS; Aplin AE Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241 [TBL] [Abstract][Full Text] [Related]
4. EBV latent membrane protein 2A orchestrates p27 Fish K; Sora RP; Schaller SJ; Longnecker R; Ikeda M Blood; 2017 Dec; 130(23):2516-2526. PubMed ID: 29074502 [TBL] [Abstract][Full Text] [Related]
5. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation. Appleman LJ; Chernova I; Li L; Boussiotis VA Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077 [TBL] [Abstract][Full Text] [Related]
6. Cks1 promotion of S phase entry and proliferation is independent of p27Kip1 suppression. Hoellein A; Graf S; Bassermann F; Schoeffmann S; Platz U; Hölzlwimmer G; Kröger M; Peschel C; Oostendorp R; Quintanilla-Fend L; Keller U Mol Cell Biol; 2012 Jul; 32(13):2416-27. PubMed ID: 22508990 [TBL] [Abstract][Full Text] [Related]
7. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells. Kim JY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim DH; Chae SW; Sohn JH World J Gastroenterol; 2014 Jan; 20(3):755-73. PubMed ID: 24574749 [TBL] [Abstract][Full Text] [Related]
9. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells. Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140 [TBL] [Abstract][Full Text] [Related]
10. Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells. Westbrook L; Manuvakhova M; Kern FG; Estes NR; Ramanathan HN; Thottassery JV Cancer Res; 2007 Dec; 67(23):11393-401. PubMed ID: 18056467 [TBL] [Abstract][Full Text] [Related]
11. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth. Pavlides SC; Lecanda J; Daubriac J; Pandya UM; Gama P; Blank S; Mittal K; Shukla P; Gold LI Cell Cycle; 2016; 15(7):931-47. PubMed ID: 26963853 [TBL] [Abstract][Full Text] [Related]
12. Two Pathways of p27 Sora RP; Ikeda M; Longnecker R mBio; 2019 Apr; 10(2):. PubMed ID: 30992353 [TBL] [Abstract][Full Text] [Related]
13. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1. Ungermannova D; Lee J; Zhang G; Dallmann HG; McHenry CS; Liu X J Biomol Screen; 2013 Sep; 18(8):910-20. PubMed ID: 23589337 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase. Hao B; Zheng N; Schulman BA; Wu G; Miller JJ; Pagano M; Pavletich NP Mol Cell; 2005 Oct; 20(1):9-19. PubMed ID: 16209941 [TBL] [Abstract][Full Text] [Related]
15. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells. Lee SH; McCormick F J Mol Med (Berl); 2005 Apr; 83(4):296-307. PubMed ID: 15605273 [TBL] [Abstract][Full Text] [Related]
17. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491 [TBL] [Abstract][Full Text] [Related]
18. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer. Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392 [TBL] [Abstract][Full Text] [Related]
19. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. O'Hagan RC; Ohh M; David G; de Alboran IM; Alt FW; Kaelin WG; DePinho RA Genes Dev; 2000 Sep; 14(17):2185-91. PubMed ID: 10970882 [TBL] [Abstract][Full Text] [Related]
20. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]